Pharmaceutical Products and Supplements
(Raw Materials + Semi-finished Products + Finished Products)
Pharmaceutical Products and Supplements
(Raw Materials + Semi-finished Products + Finished Products)
Pharmaceutical Products and Supplements
(Raw Materials + Semi-finished Products + Finished Products)
Product type
Semi-finished pharmaceutical products
Experience, Expertise, Trust
More than 30 years of experience in the pharmaceutical industry
Advanced technology
Using up-to-date knowledge
Where do we stand?
As one of the key pillars in the value chain of the Kimiagaran Emroz Development Group, we are committed to the sustainable production and supply of high-quality raw materials and semi-finished pharmaceutical products, based on up-to-date knowledge and new technologies. Our activities are designed within the framework of national and international standards, with the aim of responding to the needs of domestic and foreign pharmaceutical companies. If necessary and based on market needs, the production of final products is also within the scope of our mission. By focusing on sustainable development, enhancing national production capacity, and playing an effective role in the country’s pharmaceutical production chain, we are committed to creating added value in the pharmaceutical industry of Iran and the region.
The company aims to adhere to its core values by establishing efficient and effective management systems, developing new and innovative products, expanding domestic and foreign markets, continuously improving productivity and sustainable organizational excellence, applying new knowledge and technologies, developing and empowering knowledge-based human capital, and fulfilling environmental and social responsibilities. It will always strive to ensure the interests of all its stakeholders.

Introducing Kimia Group
The Kimia Group is a leading holding company in Iran’s petrochemical, chemical, and pharmaceutical industries; in recent years, it has emerged as a reputable brand in the sector, driven by the goal of fostering strategic synergy among its subsidiaries and completing the value chain from petrochemicals to pharmaceuticals (P2P).
Apirapharma Pharmaceutical Company
apirapharma is a leading company in the field of production and development of innovative drugs and high-quality pharmaceutical products. Using advanced technologies and a team of experts, the company strives to meet the needs of the pharmaceutical market by providing innovative and efficient solutions. apirapharma has a special focus on research and development and, in cooperation with scientific and research centers, produces its products based on international standards to ensure the health and satisfaction of consumers.
In addition to producing medicines, Epirapharma is also active in providing consulting services and scientific support, and aims to improve the quality of life of patients by facilitating access to effective and safe treatments. The company, adhering to ethical principles and a commitment to social responsibility, plays an important role in promoting the health of society and is recognized as one of the key players in the pharmaceutical industry in the region.